Discover expert-relief solutions for managing atopic dermatitis, from breakthrough treatments to daily habits that prevent ...
Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data ...
Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback